FDA Approved: OMIDRIA — Supplemental Application (Rayner Surgical Inc.)

View source ↗

Summary

FDA approved a supplemental application for OMIDRIA, a phenylephrine and ketorolac combination, submitted by Rayner Surgical Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Omidria (phenylephrine/ketorolac intraocular solution)

Snippet

SUPPL AP for OMIDRIA (PHENYLEPHRINE AND KETOROLAC)